Education
About Us
Working with TipRanks
Follow Us
Amrize Ltd (AMRZ)
NYSE:AMRZ
Top Page
Amrize Ltd
(NYSE:AMRZ)
Select Model
Select Model
Rating:70Outperform
Price Target:
$52.00
▼(-6.86% Downside)
Amrize Ltd's overall stock score is driven by strong financial performance and positive earnings call sentiment, indicating robust growth prospects. However, technical analysis suggests bearish momentum, and valuation metrics show moderate attractiveness. The absence of a dividend yield may deter some investors.
Positive Factors
Revenue Growth
The consistent revenue growth indicates robust demand for Amrize's products, enhancing its market position and supporting long-term expansion.
Margin Expansion
Sustained margin expansion through operational efficiencies strengthens profitability, allowing for reinvestment in growth and innovation.
Free Cash Flow
Increased free cash flow enhances financial flexibility, enabling strategic investments and debt reduction, supporting long-term stability.
Negative Factors
Residential Construction Softness
Softness in residential construction may limit growth in this segment, affecting revenue diversification and increasing reliance on other sectors.
Cement Network Equipment Outage
Equipment outages leading to higher costs can impact profitability and operational efficiency, posing risks to cost management strategies.
Cement Pricing Pressure
Pricing pressure in the cement market may compress margins, challenging Amrize's ability to maintain profitability in this segment.
Amrize Ltd (AMRZ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$31.12B
Dividend YieldN/A
Average Volume (3M)4.56M
Price to Earnings (P/E)26.2
Beta (1Y)0.99
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
EmployeesN/A
SectorBasic Materials
Sector Strength58
IndustryConstruction Materials
Share Statistics
EPS (TTM)0.98
Shares Outstanding552,735,960
10 Day Avg. Volume1,289,263
30 Day Avg. Volume4,564,079
Financial Highlights & Ratios
PEG Ratio0.62
Price to Book (P/B)2.90
Price to Sales (P/S)2.46
P/FCF Ratio17.54
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue2.78
Enterprise Value/Gross Profit10.78
Enterprise Value/Ebitda11.76
Forecast
1Y Price Target
$59.46Price Target Upside6.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Amrize Ltd Business Overview & Revenue Model
Company DescriptionAmrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
How the Company Makes MoneyAmrize Ltd generates revenue primarily through the sale of its software solutions and subscription-based services. The core revenue streams include licensing fees from healthcare providers for the use of its telehealth platforms and EHR systems, as well as recurring subscription fees for ongoing support and updates. Additionally, the company has established strategic partnerships with various healthcare organizations and technology firms, which not only enhance its product offerings but also contribute to increased market reach and customer acquisition. These collaborations often result in joint ventures or revenue-sharing agreements that further bolster Amrize's earnings.
Amrize Ltd Earnings Call Summary
Earnings Call Date:Oct 28, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Feb 19, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted strong revenue growth and free cash flow, successful margin expansion in Building Envelope, and progress in the ASPIRE synergy program, alongside a positive demand outlook. However, challenges included a temporary equipment outage in the cement network, softness in residential construction, and cement pricing pressure.Q3-2025 Updates
Positive Updates
Strong Revenue Growth
Amrize delivered strong revenue growth of 6.6%, driven by continued infrastructure demand and an improving commercial market.
Free Cash Flow Increase
The company generated strong free cash flow of $674 million, up $221 million from the prior year.
Successful Margin Expansion
Building Envelope business delivered substantial margin expansion driven by operational efficiencies and lower raw material costs.
Project ASPIRE Progress
Excellent progress in the ASPIRE synergy program with over 300 new logistics and service providers onboarded and more than 100 projects launched.
Positive Demand Outlook
Raising 2025 revenue guidance with strong long-term demand expected from infrastructure, modernization, and data center expansion.
Negative Updates
Cement Network Equipment Outage
Temporary equipment outage in the cement network resulted in approximately $50 million of higher manufacturing and distribution costs.
Year-over-Year Adjusted EBITDA Comparison Impact
The comparison was affected by a material asset sale in the third quarter of last year.
Residential Construction Softness
Residential volumes were down due to soft new construction activity and a milder storm season.
Cement Pricing Pressure
Cement pricing for the quarter was down 0.6%, reflecting softer demand.
Company Guidance
During the Amrize Q3 2025 earnings call, the company provided guidance and updates on several performance metrics. Amrize reported a 6.6% increase in revenue, driven by infrastructure demand and improvement in the commercial market. Despite a temporary equipment outage in the cement network causing higher costs, the company achieved strong free cash flow of $674 million, up $221 million from the previous year. Building Materials revenue rose by 8.7%, with cement volumes increasing by 6% and aggregates by 3.3%. The Building Envelope segment saw a 0.7% revenue increase, with adjusted EBITDA margins expanding by 190 basis points due to operational efficiencies and lower raw material costs. The company confirmed its adjusted EBITDA guidance for the year at $2.9 billion to $3.1 billion and expects a net leverage ratio below 1.5x. Amrize continues to invest in organic growth projects, including expansions at its Ste. Gen and St. Constant plants. Looking forward, the company remains optimistic about long-term demand driven by megatrends like infrastructure modernization and data center expansion.Amrize Ltd Financial Statement Overview
Summary
Amrize Ltd exhibits strong financial health with improving profitability and leverage metrics. The company has effectively managed its debt levels while maintaining robust margins. Despite a temporary dip in free cash flow growth, the cash flow position remains solid, supporting future growth prospects.Income Statement
Amrize Ltd has demonstrated strong profitability with a consistent increase in gross profit margin from 23.05% in 2022 to 26.23% in 2024. The net profit margin also improved significantly from 8.19% in 2023 to 12.12% in 2024, indicating enhanced operational efficiency. Revenue growth has been steady, with a notable increase of 8.87% in 2023. EBIT and EBITDA margins have shown positive trends, reflecting robust core business performance.Balance Sheet
The company's balance sheet indicates a solid financial position with a declining debt-to-equity ratio from 1.05 in 2022 to 0.43 in 2024, suggesting improved leverage management. Return on equity remains stable, showcasing effective use of shareholder funds. The equity ratio is not explicitly provided, but the reduction in debt levels enhances financial stability.Cash Flow
Amrize Ltd's cash flow analysis shows a healthy operating cash flow to net income ratio, improving from 0.83 in 2023 to 0.94 in 2024. However, free cash flow growth was negative in 2023, indicating potential challenges in cash generation. The free cash flow to net income ratio remains strong, reflecting efficient cash conversion.| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 11.82B | 11.70B | 11.68B | 10.73B |
| Gross Profit | 3.05B | 3.07B | 2.77B | 2.47B |
| EBITDA | 2.80B | 3.01B | 2.70B | 2.50B |
| Net Income | 1.38B | 1.42B | 956.00M | 1.11B |
Balance Sheet | ||||
| Total Assets | 24.04B | 23.80B | 23.05B | 20.67B |
| Cash, Cash Equivalents and Short-Term Investments | 826.00M | 1.82B | 1.11B | 351.00M |
| Total Debt | 6.89B | 5.79B | 9.52B | 8.66B |
| Total Liabilities | 11.14B | 13.89B | 13.84B | 12.46B |
| Stockholders Equity | 12.90B | 9.91B | 9.20B | 8.21B |
Cash Flow | ||||
| Free Cash Flow | 1.42B | 1.64B | 1.41B | 1.50B |
| Operating Cash Flow | 2.13B | 2.28B | 2.04B | 1.99B |
| Investing Cash Flow | -563.00M | -1.21B | -2.02B | -2.52B |
| Financing Cash Flow | -1.14B | -537.00M | 734.00M | 497.00M |
Amrize Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $17.84B | 12.78 | 7.10% | 0.74% | -6.34% | 210.97% | |
77 Outperform | $39.20B | 35.26 | 13.56% | 0.67% | 6.54% | 32.48% | |
74 Outperform | $2.42B | 13.53 | 26.21% | 1.12% | 15.70% | 19.92% | |
73 Outperform | $38.72B | 33.82 | 11.63% | 0.51% | 1.99% | -41.08% | |
72 Outperform | $12.03B | 44.85 | 4.63% | ― | -1.59% | -15.58% | |
70 Outperform | $31.12B | 26.21 | ― | ― | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
AMRZ
Amrize Ltd
55.83
2.83
5.34%
CX
Cemex SAB
11.92
6.29
111.84%
MLM
Martin Marietta Materials
646.24
131.96
25.66%
VMC
Vulcan Materials
299.85
46.45
18.33%
TGLS
Tecnoglass
50.77
-23.21
-31.37%
JHX
James Hardie Industries PLC
21.41
-6.94
-24.48%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.